Key Takeaways Pfizer posted Q1 earnings of $0.92 per share, crushing EPS expectations of$0.64 by 43%. Trading near multi-year lows of $20 a share, investors may be eyeing Pfizer's stock for a continued rebound. Pfizer is on track to exceed its net cost savings targets amid declining revenue from COVID-related products.Pfizer (PFE)  shares spiked +3% in Tuesday’s trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations this morning. Still, Pfizer stock has fallen 10% year ...